Final overall survival for the phase 3 KN177 study: Pembrolizumab versus chemotherapy in microsatellite instability-high/mismatch repair deficient metastatic colorectal cancer Meeting Abstract
| Authors: | André, T.; Shiu, K.; Kim, T.; Jensen, B.; Jensen, L.; Punt, C.; Smith, D.; Garcia-Carbonero, R.; Alcaide García, J.; Gibbs, P.; De la Fouchardière, C.; Rivera Herrero, F.; Elez, E.; Bendell, J.; Le, D.; Yoshino, T.; Zhong, W.; Fogelman, D.; Marinello, P.; Diaz, L. Jr |
| Abstract Title: | Final overall survival for the phase 3 KN177 study: Pembrolizumab versus chemotherapy in microsatellite instability-high/mismatch repair deficient metastatic colorectal cancer |
| Meeting Title: | ESMO 23rd World Congress on Gastrointestinal Cancer |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2021 Jun 30-Jul 3 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-07-01 |
| Start Page: | S220 |
| End Page: | S221 |
| Language: | English |
| ACCESSION: | WOS:000670004200338 |
| DOI: | 10.1016/j.annonc.2021.05.012 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: O-8 -- Source: Wos |
